Exagen Inc. (XGN) has seen some recent activity in the stock market and its common shares were last quoted at $12.28 yesterday. Investors are starting to take interest of XGN as the common shares traded as high as $12.28 and as low as $11.75 in the prior market trading session.
Exagen Inc. (XGN) average trading volume is 38.68K. However, in the prior market trading session Exagen Inc. (XGN) traded 68,599 shares. The First downside support level on XGN is $11.05 and the First resistance level on XGN is $20.82. XGN 50day moving average is $13.87 and XGN 200day moving average is $14.23.
Exagen Inc. (XGN) current performance has been specified by the recent movement in XGN common shares. XGN has performed -11.59% over the past 4 weeks, XGN has performed -3.91% over the past 90 days and XGN has shown – over the past 12 months. Exagen Inc. (XGN) has a 1 year range of $10.29 to $29.86. Exagen Inc. (XGN) is trading 19.34% from its 1 year low and -58.87% from its 1 year high. Exagen Inc. (XGN) is indicating a 3.15% short float indicating the sum short in the float.
XGN has 12.64M shares outstanding and 5.17M shares in the float. Exagen Inc. (XGN) at this time has a market cap of $153.25M and income of -29.40M. The EPS next quarter for XGN is -0.50 and forecasted EPS next year is 20.60%. The market cap of Exagen Inc. (XGN) at $153.25M signifies how many Investors own shares of XGN and is calculated off the last price ($12.28) of XGN and the sum of shares outstanding (12.64M) with Exagen Inc. (XGN).
Exagen Inc. (XGN) has aggregate cash (mrq) of 63.7M, aggregate cash per share (mrq) of 5.04, aggregate debt of XGN rests at 27.01M and aggregate debt/equity (mrq) is 56.46. . Exagen Inc. (XGN) operating cash flow (ttm) is -13.65M, XGN leveraged free cash flow (ttm) is -10.1M.
XGN is trading -17.58% below (bearish) its SMA20, -6.48% below (bearish) its SMA50 and -25.08% below (bearish) its SMA200.